Furthermore, the pathophysiological role of CD80 in FSGS is not excluded, since the use of abatacept (CTLA-4-Ig) has been shown to reduce substantially proteinuria in FSGS [77]. Here, CD80 is linked to focal segmental glomerulosclerosis.